New Studies Point to a Signature for ME/CFS: Will They Lead to Widely Used Diagnostic Tests?
By Oved Amitay, Solve M.E. President and CEO Three studies were published last week, describing incredibly intriguing data, each pointing to specific biomarkers that can help to identify people with […]
The Path to Diagnostics for ME/CFS: Can Long Covid Pave a Short-Cut?
By Oved Amitay, President and CEO, Solve M.E. It is often said that there are no biomarkers for ME/CFS. In fact, a number of objective measurable biological differences between people […]
